
    
      Phase Ib trial investigating the combination of intraperitoneal Cisplatin (10.5 mg/m2) and
      Nab-paclitaxel (escalated dose from 7.5 mg/m2 to 70 mg/m2) administered by pressurized
      intraperitoneal aerosol chemotherapy (PIPAC) every 4-6 weeks for 3 cycles.
    
  